Challenges for children and adolescents with cancer in Europe: The SIOP-Europe agenda

Pediatric Blood and Cancer

Volumn 61, Issue 9, 2014, Pages 1551-1557

  Vassal, Gilles ^a   Fitzgerald, Edel ^b   Schrappe, Martin ^c   Arnold, Frédéric ^d,e   Kowalczyk, Jerzy ^f   Walker, David ^g   Hjorth, Lars ^h   Riccardi, Riccardo ⁱ   Kienesberger, Anita ^e   Jones, Kathy Pritchard ^j   Valsecchi, Maria Grazia ^k   Janic, Dragana ^l   Hasle, Henrik ^m   Kearns, Pamela ⁿ   Petrarulo, Giulia ^b   Florindi, Francesco ^b   Essiaf, Samira ^b   Ladenstein, Ruth ^o  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b SIOP Europe Office   (Belgium)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d Union Nationale des Associations de Parents d'Enfants atteints de Cancer ou Leucemie (UNAPECLE)   (France)

^e International Confederation of Childhood Cancer Parent Organization (ICCCPO)   (Netherlands)

^f MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^g UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY OF MILANO BICOCCA   (Italy)

^l UNIVERSITY OF BELGRADE   (Serbia)

^m AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁿ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^o CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

more..

Author keywords

Cancer; Care; Education; Oncopolicy; Research

Indexed keywords

ADOLESCENT DISEASE; ARTICLE; CANCER MORTALITY; CANCER SURVIVOR; CHILDHOOD CANCER; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); EUROPE; EUROPEAN UNION; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEMATOLOGY; HUMAN; LONG TERM CARE; MEDICAL EDUCATION; MEDICAL SOCIETY; MEDICAL SPECIALIST; ONCOLOGY; PARENT; PATIENT CARE; PRIORITY JOURNAL; TRANSLATIONAL RESEARCH;

CANCER; CARE; EDUCATION; ONCOPOLICY; RESEARCH;

ADOLESCENT; CHILD; EUROPE; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT-CENTERED CARE; QUALITY OF HEALTH CARE;

EID: 84904439264     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25044     Document Type: Article

References (35)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-2917.
2. Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999-2007: Results of EUROCARE-5-a population-based study. Lancet Oncol 2014; 15:35-47.
3. Pritchard-Jones K, Pieters R, Reaman GH, et al. Sustaining innovation and improvement in the treatment of childhood cancer: Lessons from high-income countries. Lancet Oncol 2013; 14:e95-e103.
4. Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, et al. Cancer in children and adolescents in Europe: Developments over 20 years and future challenges. Eur J Cancer 2006; 42:2183-2190.
5. Calaminus G, Birch JR, Hollis R, et al. The role of SIOP as a platform for communication in the global response to childhood cancer. Pediatr Blood Cancer 2013; 60:2080-2086.
6. The European Cancer Organisation. www.ecco-org.eu (accessed on 1st November 2013).
7. Schilsky RL. Personalized medicine in oncology: The future is now. Nat Rev Drug Discov 2010; 9:363-366.
8. Marris S, Morgan S, Stark D. " Listening to Patients": What is the value of age-appropriate care to teenagers and young adults with cancer? Eur J Cancer Care (Engl) 2011; 20:145-151.
9. Sullivan R, Kowalczyk JR, Agarwal B, et al. New policies to address the global burden of childhood cancers. Lancet Oncol 2013; 14:e125-e135.
10. The European Network for Cancer research in Children and Adolescents www.encca.eu (accessed on 1st November 2013).
11. The European Partnership for Actions Against Cancer. www.epaac.eu (accessed 1st November 2013).
12. The Eurocanplatform. www.eurocanplatform.eu (accessed 1st November 2013).
13. Kowalczyk JR, Samardakiewicz M, Fitzgerald E, et al. Towards reducing inequalities: European Standards of Care for Children with Cancer. Eur J Cancer 2014; 50:481-485.
14. PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies (PanCaerSurFup). www.pancaresurfup.eu (accessed 1st November 2013).
15. The International Study for treatment of Childhood relapsed acute lymphoblastic leukaemias. http://www.intreall-fp7.eu (accessed 1st November 2013).
16. Maru M, Gibson F, Hinds PS. Pediatric oncology nursing research goes global. Cancer Nurs 2013; 36:339. DOI: 10.1097/NCC.0b013e3182a34688
17. Brasme JF, Morfouace M, Grill J, et al. Delays in diagnosis of paediatric cancers: A systematic review and comparison with expert testimony in lawsuits. Lancet Oncol 2012; 13:e445-e459.
18. Headsmart-be brain tumour aware. www.headsamart.org.uk (accessed 1st November 2013).
19. Rowland JH, Kent EE, Forsythe LP, et al. Cancer survivorship research in Europe and the United States: Where have we been, where are we going, and what can we learn from each other? Cancer 2013; 119:2094-2108.
20. The SIOPE syllabus-European training programme in paediatric haematology and oncology. http://www.siope.eu/wp-content/uploads/2013/11/European-training-Paediatrics_New.pdf (accessed 1st November 2013).
21. The International Confederation of Childhood Cancer Parents Organisation. http://www.icccpo.org
22. Les Aguerris. www.lesaguerris.wordpress.com (accessed 1st November 2013).
23. SurvivorNet. http://SurvivorNet.org (accessed 1st November 2013).
24. UngCancer. www.ungcancer.se (accessed 1st November 2013).
25. Hartmann M. Impact assessment of the European Clinical Trials Directive: A longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries. Trials 2012; 13:53.
26. Willmott G. Regulating clinical trials in Europe. Lancet Oncol 2013; 14:453-454.
27. Kearns P. The need for proportionate regulation of clinical trials. Lancet Oncol 2013; 14:454-455.
28. Olski TM, Lampus SF, Gherarducci G, et al. Three years of paediatric regulation in the European Union. Eur J Clin Pharmacol 2011; 67:245-252.
29. Vassal G, Geoerger B, Morland B. Is the European pediatric medicine regulation working for children and adolescents with cancer? Clin Cancer Res 2013; 19:1315-1325.
30. Saint-Raymond A, Herold R. Medicines for pediatric oncology: Can we overcome the failure to deliver? Expert Rev Clin Pharmacol 2012; 5:493-495.
31. Vassal G, Blanc P, Pearson A. Need for change in implementation of paediatric regulation. Lancet Oncol 2013; 14:1156-1157.
32. The International BFM study group. www.bfm-international.org (accessed 1st November 2013).
33. Vassal G, Zwaan CM, Ashley D, et al. New drugs for children and adolescents with cancer: The need for novel development pathways. Lancet Oncol 2013; 14:e117-e124.
34. Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: An INRG Task Force report. J Clin Oncol 2009; 27:298-303.
35. Malogolowkin M, Spreafico F, Dome JS, et al. Incidence and outcomes of patients with late recurrence of Wilms' tumor. Pediatr Blood Cancer 2013; 60:1612-1615.